文献速递糖尿病

2型糖尿病血糖控制与脓毒症风险及后续死亡率

Glycemic Control and Risk of Sepsis and Subsequent Mortality in Type 2 Diabetes.
PubMed 文献 · Diabetes Care · 2022-01-01

基于瑞典国家糖尿病登记中502,871例2型糖尿病患者,采用多变量Cox回归和限制性立方样条分析,发现HbA1c与脓毒症发生呈U型关联,脓毒症患者全因死亡风险约为无脓毒症者的4倍。

要点

  • HbA1c与脓毒症风险呈U型关联,过低或过高均增加风险。
  • HbA1c>82 mmol/mol(9.7%)时脓毒症风险显著升高,aHR 1.52。
  • 发生脓毒症的2型糖尿病患者全因死亡风险约为无脓毒症者的4倍。

核心结论

  • 在2型糖尿病全国性队列中,HbA1c与脓毒症发生呈U型关联,且脓毒症患者死亡风险增加约四倍。

研究设计与样本

  • 采用多变量Cox回归分析脓毒症与死亡的关联。

主要发现

  • 研究期间共14,534例(2.9%)患者发生脓毒症。
  • 以HbA1c 48-52 mmol/mol(6.5-6.9%)为参照,HbA1c<43 mmol/mol(6.1%)的脓毒症调整风险比HR为1.15(95%CI 1.07-1.24)。
  • HbA1c 53-62 mmol/mol(7.0-7.8%)的HR为0.93(0.87-0.99),63-72 mmol/mol(7.9-8.7%)为1.05(0.97-1.13),73-82 mmol/mol(8.8-9.7%)为1.14(1.04-1.25),>82 mmol/mol(9.7%)为1.52(1.37-1.68)。
  • 立方样条模型中,调整后风险在较低HbA1c范围内下降至53 mmol/mol(7.0%),每SD的HR为0.78(0.73-0.82),此后风险上升(非线性P<0.001)。
  • 与无脓毒症患者相比,脓毒症患者的调整死亡HR为4.16(4.03-4.30)。

临床怎么用

  • 2型糖尿病患者的HbA1c管理需兼顾过低与过高风险,HbA1c在53 mmol/mol(7.0%)左右可能与最低脓毒症风险相关。
  • 对发生脓毒症的2型糖尿病患者应警惕其显著升高的死亡风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate the nature of the relationship between HbA1c and sepsis among individuals with type 2 diabetes, and to assess the association between sepsis and all-cause mortality in such patients. RESEARCH DESIGN AND METHODS: We included 502,871 individuals with type 2 diabetes recorded in the Swedish National Diabetes Register and used multivariable Cox regression and restricted cubic spline analyses to assess the association between time-updated HbA1c values and sepsis occurrence between 1 January 2005 and 31 December 2015. The association between sepsis and death was examined using multivariable Cox regression analysis. RESULTS: Overall, 14,534 (2.9%) patients developed sepsis during the study period. On multivariable Cox regression analysis, compared with an HbA1c of 48-52 mmol/mol (6.5-6.9%), the adjusted hazard ratio for sepsis was 1.15 (95% CI 1.07-1.24) for HbA1c <43 mmol/mol (6.1%), 0.93 (0.87-0.99) for HbA1c 53-62 mmol/mol (7.0-7.8%), 1.05 (0.97-1.13) for HbA1c 63-72 mmol/mol (7.9-8.7%), 1.14 (1.04-1.25) for HbA1c 73-82 mmol/mol (8.8-9.7%), and 1.52 (1.37-1.68) for HbA1c >82 mmol/mol (9.7%). In the cubic spline model, a reduction of the adjusted risk was observed within the lower HbA1c range until 53 mmol/mol (7.0%), with a hazard ratio of 0.78 (0.73-0.82) per SD; it increased thereafter (P for nonlinearity <0.001). As compared with patients without sepsis, the adjusted hazard ratio for death among patients with sepsis was 4.16 (4.03-4.30). CONCLUSIONS: In a nationwide cohort of individuals with type 2 diabetes, we found a U-shaped association between HbA1c and sepsis and a fourfold increased risk of death among those developing sepsis.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Balintescu A, Lind M, Franko MA, et al. Glycemic Control and Risk of Sepsis and Subsequent Mortality in Type 2 Diabetes. Diabetes Care. 2022. PMID: 34716212. doi:10.2337/dc21-1050

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。